Tomoko Motomiya

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 2

Top Topics

Major Depressive Disorder

Top Venues

Psychiatry and clinical neurosciences

Neuropsychopharmacology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Takuhiro Sonoyama, Ryosuke Shimizu, Ryuji Kubota, Yumiko Matsuo, Daiki Okutsu, Hideki Yamanaka, Keiko Takasu, Koichi Ogawa, Tomoko Motomiya
Pharmacokinetics, safety, and tolerability of single and multiple doses of zuranolone in Japanese and White healthy subjects: A phase 1 clinical trial. Neuropsychopharmacology reports (2023)
Masaki Kato, Kazuyuki Nakagome, Takamichi Baba, Takuhiro Sonoyama, Daiki Okutsu, Hideki Yamanaka, Ryosuke Shimizu, Tomoko Motomiya, Takeshi Inoue
Efficacy and safety of zuranolone in Japanese adults with major depressive disorder: A double-blind, randomized, placebo-controlled, phase 2 clinical trial. Psychiatry and clinical neurosciences (2023)